Real Time Touch

new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)

Real Time Touch

Vaxinnate Corporation patents (2016 archive)

Recent patent applications related to Vaxinnate Corporation. Vaxinnate Corporation is listed as an Agent/Assignee. Note: Vaxinnate Corporation may have other listings under different names/spellings. We're not affiliated with Vaxinnate Corporation, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "V" | Vaxinnate Corporation-related inventors

Flagellin fusion proteins

Methods of making a protein that stimulates a protective immune response in a subject include separating a portion of a protein from a naturally occurring influenza viral hemagglutinin to form a protein portion.. . ... Vaxinnate Corporation

Deletion mutants of flagellin and methods of use

Compositions that include at least a portion of a flagellin and an antigen can be employed in methods that stimulate an immune response in a subject, in particular, a protective immune response in a subject. Compositions can be associated with particles and employed in the methods in relatively low doses to provide protective immunity to infection.. ... Vaxinnate Corporation

Clostridium difficile compositions and methods of use

Fusion proteins include full-length flagellin or portions of flagellin fused to at least one clostridium difficile antigen. Fusion proteins can include a first clostridium difficile antigen that replaces at least a portion or the entirety of domain 3 of flagellin and a second clostridium difficile antigen fused to the carboxy terminal amino acid of flagellin. ... Vaxinnate Corporation

Methods of stimulating immunity employing dengue viral antigens

Compositions that include at least a portion of at least one pathogen-associated molecular pattern and at least a portion of at least one member selected from the group consisting of a den1 viral envelope protein, a den2 viral envelope protein, a den3 viral envelope protein and a den4 viral envelope protein are employed in methods to stimulate a protective immune response in a subject.. . ... Vaxinnate Corporation

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009


This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. is not affiliated or associated with Vaxinnate Corporation in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Vaxinnate Corporation with additional patents listed. Browse our Agent directory for other possible listings. Page by